Make the MenB patient discussion part of the decision to vaccinate
The best way to achieve shared clinical decision-making is to have a discussion about MenB. Remember that patients and parents may not know what MenB is—that’s why it’s important for you to start the conversation
REVIEW what meningococcal disease is, as well as the potential consequences and their rapid progression
LIST the behavioral risk factors that can lead to contracting MenB
EXPLAIN the differences between serogroups ACWY and B and the 2 different types of vaccines
RECOMMEND that your appropriate patients start the MenB vaccination series
EMPHASIZE the importance of series completion and schedule their second dose
Vaccination may not protect all recipients.
CDC=Centers for Disease Control and Prevention.
References: 1. Walker TY, Elam-Evans LD, Yankey D, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2018. MMWR. 2019;68(33):718-723. 2.Centers for Disease Control and Prevention. Immunization schedules: Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2020. https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf. Updated February 3, 2020. Accessed February 6, 2020. 3. US Department of Health and Human Services. The Affordable Care Act and Reconciliation ACT. https://www.hhs.gov/sites/default/files/ppacacon.pdf. Updated June 10, 2010. Accessed February 3, 2020. 4. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices. Vaccines for Children Program: Vaccines to prevent meningococcal disease. Resolution No. 6/19-7. https://www.cdc.gov/vaccines/programs/vfc/downloads/resolutions/2019-6-7-mening-508.pdf. Effective June 27, 2019. Accessed February 4, 2020.